Abstract
Adenosine is a nucleoside which consists of the purine base adenine linked to ribose (Fig. 1). It is produced by two main enzymatic reactions involving dephosphorylation of 5′-nucleotidase (EC 3.1.5.5) and alkaline phosphatase (EC 3.1.3.1) as well as hydrolysis of S-adenosyl-l-homocysteine (SAH) by SAH-hydrolase (3.3.1.1). Adenosine may be formed intracellularly, as a result of a breakdown of cytosolic adenosine 5′-triphosphate (ATP), or extracellularly from ATP. In nerve tissue, an increase in nerve firing releases both adenosine and ATP, which is then extracellularly degraded to adenosine (Stone et al. 1990).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agarwal RP, Spector T, Parks RE (1977) Tight-binding inhibitors. IV. Inhibition of adenosine deaminase by various inhibitors. Biochem Pharmacol 26:359–367
Berne RM, Rubio R, Curnish RR (1974) Release of adenosine from ischaemic brain: effect on cerebral vascular resistance and incorporation into cerebral adenine nucleotides. Circ Res 35:262–271
Bhattacharya IC, Goldstein L, Pfeiffer CC (1970) Influence of acute and chronic nicotine administration on EEG reactivity to drugs in rabbits. I. Nucleosides and nucleotides. Res Commun Chem Pathol Pharmacol 1:99–108
Bruns RF, Lu GH, Pugsley TA (1986) Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. J Pharmacol Exp Ther 29:331–346
Bruns RF, Fergus JH, Badger EW, Bristol JA, Santay LA, Hartman JD, Hays SJ, Huang CC (1987a) Binding of the A1-selective adenosine antagonist 8 cyclopentyl-l,3-dipropylxanthine to rat brain membranes. Naunyn Schmiedebergs Arch Pharmacol 335:59–63
Bruns RF, Fergus JH, Badger EW, Bristol JA, Santay LA, Hays SJ (1987b) PD115–199: an antagonist ligand for adenosine A2 receptors. Naunyn Schmiedebergs Arch Pharmacol 335:64–69
Buday PV, Carr CJ, Miya TS (1961) A pharmacologic study of some nucleosides and nucleotides. J Pharm Pharmacol 13:290–299
Chagoya DeSanchez V, Hernandez-Munoz R, Diaz-Munoz M, Suarez J, Vidrio S, Yanez L (1983) Circadian variations of adenosine and its physiological meaning in the energetic homeostasis of the cell and the sleep-wake cycle of the rat. 4th International Congress on Sleep Research, Washington, p 255
Daly JW, Butts-Lamb P, Padgett W (1983) Subclasses of adenosine receptors in the central nervous system: interactions with caffeine and related methylxanthines. Cell Mol Pharmacol 3:69–80
Dolphin AC, Prestwich SA, Forda SR (1985) Presynaptic modulation by adenosine analogues: relationship to adenylate cyclase. In: Stefanovich V, Rudolphi E, Schubert P (eds) Adenosine modulation of cell function. IRL, Oxford, p 107
Dunwiddie TV, Worth T (1982) Sedative and anti-convulsant effects of adenosine analogs in mouse and rat. J Pharmacol Exp Ther 220:70–76
Feldberg W, Sherwood SL (1954) Injections of drugs into the lateral ventricle of the cat. J Physiol (Lond) 123:148–167
Haas HH, Greene RW (1988) Endogenous adenosine inhibits hippocampal CAI neurons: further evidence from extra- and intra-cellular recordings. Naunyn Schmiedebergs Arch Pharmacol 337:561–565
Harms HH, Warden G, Mulder AH (1979) Effects of adenosine on depolarization-induced release of various radiolabeled neurotransmitters from slices of rat corpus striatum. Neuropharmacology 18:577–580
Haulica I, Ababei L, Branisteanu D, Topoliceanu F (1973) Preliminary data on the possible hypnogenic role of adenosine. J Neurochem 21:1019–1020
Hawkins M, Pravica M, Radulovacki M (1988a) Chronic administration of diazepam downregulates adenosine receptors in the rat brain. Pharmacol Physiol Behav 21:479–482
Hawkins M, Hajduk P, O’Connor S, Radulovacki M, Starz KE (1988b) Effects of prolonged administration of triazolam on adenosine A1 and A2 receptors in the brain of rats. Brain Res 505:141–144
Hedquist P, Fredholm BB (1976) Effects of adenosine on adrenergic neurotransmission: prejunctional inhibition and postjunctional enhancement. Naunyn Schmiedebergs Arch Pharmacol 293:217–224
Kafka MS, Wirz-Justice A, Naber D, Moore RY, Benedito MA (1983) Circadian rhythms in rat brain neurotransmitter receptors. Fed Proc 42:2796
Klabunde RE (1983) Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol 93:21–26
Loew DM, Spiegel R (1976) Polygraphic sleep studies in rats and humans. Their use in psychopharmacologic research. Arzneimittelforschung 26:1032–1035
Londos C, Cooper MF, Wolff J (1980) Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 77:2551–2554
Marangos PJ, Boulenger JP, Patel J (1985) Effects of chronic caffeine on brain adenosine receptors: regional and ontogenic studies. Life Sci 34:899–907
Marley E, Nistico G (1972) Effects of catecholamines and adenosine derivatives given into the brain of fowls. Br J Pharmacol 46:619–636
Martinson EA, Johnson PA, Wells JN (1987) Potent adenosine receptor antagonists that are selective for the A1 receptor subtype. Mol Pharmacol 31:247–252
Mathieu-Levy N (1968) Contribution à l’étude du mechanisme de la potentialisation du sommeil experimental par l’acide adenosine triphosphorique (ATP). Sur quelques actions d’ATP au niveu du système nerveaux central. Therapie 23: 1157–1173
Mendelson WB, Guthrie RD, Frederick G, Wyatt RJ (1974) The flowerpot technique of rapid eye movement (REM) sleep deprivation. Pharmacol Biochem Behav 2:553–556
Mereu GP, Scarnatti E, Paglietti E, Chessa P, Chicara G, Gessa GI (1979) Sleep induced by low doses of apomorphine in rats. Electroencephalogr Clin Neurophysiol 46:214–219
Michaelis ML, Michaelis EK, Myers SL (1979) Adenosine modulation of synaptosomal dopamine release. Life Sci 24:2083–2092
O’Connor SD, Hawkins M, Radulovacki M (1991) The effect of soluflazine on adenosine receptors in the rat brain. Neuropsychopharmacology 30:93–95
O’Regan MH, Phillis JW (1988) Potentiation of adenosine-evoked depression on rat cerebral cortical neurons by triazolam. Brain Res 445:376–379
Phillis JW (1979) Diazepam potentiation of purinergic depression of central neurons. Can J Physiol Pharmacol 57:432–435
Phillis JW, Wu PH (1981) The role of adenosine and its nucleotides in central synaptic transmission. Prog Neurobiol 16:187–193
Phillis JW, Wu PH (1982) Adenosine and benzodiazepine action. In: Usdin E, Skolnick P, Tallman JF, Greenblatt D, Paul SM (eds) Adenosine and benzodiazepine action. Macmillan, London, p 497
Phillis JW, Kostopoulos GK, Limacher JJ (1974) Depression of corticospinal cells by various purines and pyrimidines. Can J Physiol Pharmacol 52:1226–1230
Phillis JW, Edstrom JP, Kostopoulos GK, Kirkpatrick JR (1979a) Effects of adenosine and adenosine nucleotides on synaptic transmission in the cerebral cortex. Can J Physiol Pharmacol 57:1289–1312
Phillis JW, Edstrom JP, Ellis SW, Kirkpatrick JR (1979b) Theophylline antagonizes flurazepam-induced depression of cerebral cortical neurons. Can J Physiol Pharmacol 57:917–920
Phillis JW, Wu PH, Bender AS (1981) Inhibition of adenosine uptake into rat brain synaptosomes by the benzodiazepines. Gen Pharmacol 12:67–70
Radulovacki M (1987) Progress in sleep. N Engl J Med 316:1275
Radulovacki M, Walowitch P, Yanik G (1980) Caffeine produces REM sleep rebound in rats. Brain Res 201:497–500
Radulovacki M, Miletich RS, Green RD (1982) N6(L-Phenylisopropyl) adenosine (L-PIA) increases slow wave sleep (S2) and decreases wakefulness in rats. Brain Res 246:178–180
Radulovacki M, Virus RM, Djuricic-Nedelson M, Green RD (1983) Hypnotic effects of deoxycoformycin in rats. Brain Res 271:392–395
Radulovacki M, Virus RM, Djuricic-Nedelson M, Green RD (1984) Adenosine analogs and sleep in rats. J Pharmacol Exp Ther 228:268–274
Radulovacki M, Virus RM, Rapoza D, Crane R (1985) A comparison of the dose response effects of pyrimidine ribonucleosides and adenosine on sleep in rats. Psychopharmcology (Berl) 87:136–140
Reddington M, Erfurth A, Lee KS (1986) Heterogeneity of binding sites of N-ethylcarboxamido-[3H] adenosine in rat brain: effects of N-ethylmaleimide. Brain Res 399:232–239
Rosenberg RS, Zepelin H, Rechtschaffen A (1979) Sleep in young and old rats. J Gerontol 34:525–532
Sawynok J, Jhamandas KH (1976) Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenosine nucleotides, and morphine: antagonism by theophylline. J Pharmacol Exp Ther 197:379–390
Skolnick P, Nimilkitpaisan Y, Stalvey I, Daley JW (1978) Inhibition of brain adenosine deaminase by 2′-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl) adenine. J Neurochem 30:1579–1583
Snyder SH, Sklar P (1984) Psychiatric progress. Behavioral and molecular actions of caffeine: focus on adenosine. J Psychiatry Res 18:91–106
Snyder SH, Katims JJ, Annau Z, Bruns RF, Daly JW (1981) Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci USA 78:3260–3264
Sterman MB, Clemente CD (1962) Forebrain inhibitory mechanisms: critical synchronization induced by basal forebrain stimulation. Exp Neurol 6:91–102
Stone TW (1981) Physiological roles of adenosine and adenosine 5′-triphosphate in the nervous system. Neuroscience 6:523–552
Stone TW, Newby AC, Lloyd HGA (1990) Adenosine release. In: Williams M (ed) The adenosine receptors. Humana, Clifton, p 173
Ten Bruggencate D, Steinberg R, Stockle H, Nicholson C (1977) Modulation of extracellular CA++ and K+-levels in the mammalian cerebellar cortex. In: Ryall RW, Kelly JS (eds) Iontophoresis and transmitter mechanisms in the mammalian central nervous system. Elsevier/North-Holland, Amsterdam, p442
Ticho SR, Radulovacki M (1991) Role of adenosine in sleep and temperature regulation in the preoptic area of rats. Pharmacol Physiol Behav 40:33–40
Ukena D, Shamin MT, Padgett W, Daly JW (1986) Analogs of caffeine: antagonists with selectivity for A2 adenosine receptors. Life Sci 39:743–750
Van Belle H (1985) Myocardial purines during ischemia, reperfusion and pharmacological protection. Mol Physiol 8:615–630
Van Calker D, Muller M, Hambrecht V (1979) Adenosine regulates, via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem 33:999–1005
Virus RM, Baglajewski T, Radulovacki M (1984a) Circadian variation of [3H]N6-(L-phenylisopropyl) adenosine binding in rat brain. Neurosci Lett 46:219–222
Virus RM, Baglajewski T, Radulovacki M (1984b) [3H]N6-(L-Phenylisopropyl) adenosine binding in brains from young and old rats. Neurobiol Aging 5:61–62
Virus RM, Ticho BS, Pilditch M, Radulovacki M (1990) A comparison of the effects of caffeine, 8-cyclopentyl theophylline, and alloxazine on sleep in rats; possible roles of central nervous system adenosine receptors. Neuropsychopharmacology 3:243–249
Williams M, Risley EA (1981) Interaction of putative anxiolyts agentic agents with central adenosine receptors. Can J Physiol Pharmacol 59:897–900
Williams M, Francis J, Ghai G, Braunwalder A, Psychoyos S, Stone GA, Cash WD (1987) Biochemical characterization of the triazoloquinazoline, CGS15843A, a novel non-xanthine adenosine antagonist. J Pharmacol Exp Ther 241:415–420
Yanik G, Radulovacki M (1987) REM sleep deprivation upregulates adenosine A1 receptors. Brain Res 402:362–364
Yanik G, Glaum S, Radulovacki M (1987) The dose response effects of caffeine on sleep in rats. Brain Res 403:177–180
Yeung SH, Green RD (1984) [3H]5′-N-ethyl-carboxamide adenosine binds to both Ra and Ri adenosine receptors in rat striatum. Naunyn Schmiedebergs Arch Pharmacol 325:218–225
Zepelin H, Whitehead WE, Rechtschaffen A (1972) Aging and sleep in the albino rat. Behav Biol 7:65–74
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Radulovacki, M. (1995). Pharmacology of the Adenosine System. In: Kales, A. (eds) The Pharmacology of Sleep. Handbook of Experimental Pharmacology, vol 116. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57836-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-57836-6_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63372-0
Online ISBN: 978-3-642-57836-6
eBook Packages: Springer Book Archive